Facts from FDA records, not medical advice. Independent reference; not affiliated with, endorsed by, or speaking for the U.S. Food and Drug Administration.
FDA Medication Tracker

New FDA-approved drugs, 2026

Brand, generic name, approval date and the use the FDA approved it for. No recommendations. Updated 2026-10-17.

So far in 2026 the FDA has approved 46 novel drugs, most recently Hovilpri (pritelivir) on October 9, 2026, to treat adults with weakened immune systems who have mucocutaneous lesions caused by herpes simplex virus infection and have not responded to other therapies. "Novel" means a new molecular entity or new biologic never before approved in the U.S.; this list excludes new uses of existing drugs, generics and biosimilars. Source: FDA CDER novel drug approvals, refreshed daily.
Weight loss & diabetesCancerBrain & mental healthInfections & vaccinesHeart & bloodImmune & inflammatoryKidney, liver & lungEyeWomen's & hormonal healthPain & anesthesiaDiagnostic & imaging agentsRare & geneticOther
202620252024

Categories are ours, sorted from FDA's wording of each use. Check each drug's FDA wording on its page.

Facts only. This site lists what the FDA has approved and what the FDA says each drug is approved for, quoted from FDA and openFDA records (we only tidy spacing and drop link labels). It gives no medical advice, no dosing, and no comparisons, and it says nothing about whether a drug is right for anyone. Talk to a licensed clinician about any medication. Records can lag or contain errors; the FDA's own pages are authoritative.